World Affordable Medicines Congress
Date: | 07-Feb-17 to 08-Feb-17 |
Location: | Catalonia Plaza Barcelona Hotel / Barcelona / Spain |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
The event unites senior executives from the generic and biosimilar industry to provide fresh insights future market trends, innovative commercial strategies and opportunities for growth for affordable medicines.
Through a mixture of plenary keynote sessions, roundtables, focused work streams,
the event will address a comprehensive range of key topics, including:
• Making medicines affordable
• CEO Panel
• Building scale and market share
• Mature and emerging market review
• Payers perspective and pricing trends
• Biosimilar development challenges
• Pharmacovogilance and post launch safety monitoring
• Clinical development strategies
• Developments in global intellectual property
• Regulatory strategy for generics and biosimilars
• How is the health policy landscape supporting affordable medicines?
• How to develop an integrated approach to biosimilar development & commercialization
Through a mixture of plenary keynote sessions, roundtables, focused work streams,
the event will address a comprehensive range of key topics, including:
• Making medicines affordable
• CEO Panel
• Building scale and market share
• Mature and emerging market review
• Payers perspective and pricing trends
• Biosimilar development challenges
• Pharmacovogilance and post launch safety monitoring
• Clinical development strategies
• Developments in global intellectual property
• Regulatory strategy for generics and biosimilars
• How is the health policy landscape supporting affordable medicines?
• How to develop an integrated approach to biosimilar development & commercialization
Exhibitors
Isabel Afonso, Head of Global Commercial Strategy and member of the Sandoz Executive Committee, Sandoz, Jean-Marie Arnaud, SVP and Head, Sanofi Generics, Sophie Opdyke, Vice President, Commercial Development, Biosimilars, Global Estbalished Pharma BU, Pfizer USA, Darius Panaligan, Vice President, Global Head of Commercial, Merck Biosimilars, Merck
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today